Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 349

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Hereditary ataxia+1

Not yet recruiting

Long‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:VO659

Prostate cancer metastatic

Not yet recruiting

Study of saruparib plus AR inhibitor drug combination in men with metastatic hormone‑sensitive prostate cancer previously treated with docetaxel or Lu‑PSMA and PSA ≥0.2 ng/mL

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate

Acne

Not yet recruiting

Low-dose isotretinoin compared with drug combination for treating acne in adult women: a two‑step randomized trial

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Adapalene

Acute myeloid leukaemia

Not yet recruiting

Study of quizartinib‑based drug combination on measurable residual disease in adults 18‑60 with acute myeloid leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Azacitidine

Renal cell carcinoma

Not yet recruiting

Efficacy of pembrolizumab drug combination in advanced renal cell carcinoma: early prediction using serum KIM-1 and MAdCAM-1

Registered drugNo placebo
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib

Adenocarcinoma gastric+1

Not yet recruiting

A Phase 3 Study of ASP2138 Plus Drug Combination in Adults with HER2‑Negative, CLDN18.2‑Positive Advanced Gastric Cancer (First‑Line Treatment)

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine

Angelman's syndrome

Not yet recruiting

Study of the safety and efficacy of intrathecal rugonersen sodium in children and adults with Angelman syndrome

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years

Renal transplant+1

Not yet recruiting

Effect of Continuing Tacrolimus on Access to a Second Kidney Transplant in Patients with Renal Transplant Failure: A Randomized Controlled Trial

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tacrolimus

Hypersomnia

Not yet recruiting

Long‑term Safety and Tolerability Study of TAK‑360 in Adults with Narcolepsy or Idiopathic Hypersomnia

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Peripheral venous disease

Not yet recruiting

Efficacy and Safety of Heparan Sulphate 120 mg Prolonged‑Release Tablets in Patients with Primary Chronic Venous Disease of the Lower Limbs

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years

Gaucher's disease type I

Not yet recruiting

Switch to once‑daily eliglustat maintains stability in adult Gaucher disease type 1 patients who are CYP2D6 intermediate or extensive metabolizers

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

Neoplasm malignant

Not yet recruiting

Study of ARV-6723 Alone or with Pembrolizumab to Assess Safety and Early Effect in Adults with Advanced Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.